This is the higher-priced of CoreAge Rx’s two advertised standard GLP-1-related options. Compare it as a compounded preparation with its own pharmacy and prescription details, not as discounted Zepbound.
- Reviewed product
- Compounded tirzepatide injection
- Public price boundary
- Advertised from $149/month
- Prescription
- Required; eligibility determined clinically
- Research date
- October 8, 2026
Identify the exact product
The homepage advertises tirzepatide from $149 per month, with included supplies and shipping and a same-price-at-every-dose statement. The public product catalog identifies it as a compounded treatment reviewed by a clinician. Actual availability and prescription details require confirmation.[source]
What the evidence applies to
Tirzepatide acts on GIP and GLP-1 receptors, but that ingredient description does not establish equivalence between a compounded preparation and the approved Zepbound product. This review does not transfer branded clinical-trial percentages to the CoreAge Rx program.[source]
Understand the complete cost
Ask for the full upfront charge and renewal structure. The catalog describes multi-month options, so a monthly equivalent may conceal a larger initial commitment. Confirm the non-refundable consultation component and what happens if treatment is unsuitable or later changes.[source]
Care, refills and practical details
The prescribing and dispensing instructions need to agree on the exact preparation. Ask the pharmacy to resolve unclear labels or concentration questions. FDA has raised concerns about dosing errors and unapproved GLP-1 products; a familiar ingredient name is not enough to dismiss those concerns.[source]
Safety questions come before the price
FDA has identified concerns including dosing errors, inappropriate dose escalation and unapproved salt forms in the compounded GLP-1 market. Obtain treatment through a licensed prescriber and pharmacy, and ask why an approved drug cannot meet the clinical need. These medicines can have serious adverse effects; a low price is not a safety assessment.[source]
Compare a genuinely similar option
A comparison with LillyDirect must account for the approved branded product, its dose-specific price and separate medical care. A comparison with Mochi must add membership and the dose-dependent medicine charge. These are different purchasing arrangements, not identical boxes at different prices.
Read the full provider review and the total-cost guide before treating any headline as the complete treatment budget.
Your questions, answered
Is the displayed price my guaranteed total?
No. It is the public price boundary recorded on the review date. The prescribed product, dose, membership, billing period and eligibility can change the amount you pay.
Did you buy or test this treatment?
No. This is a source-based product and access review. We did not obtain a prescription, purchase medication or independently test treatment results.
Sources & further reading
Provider pages establish what a brand markets. Clinical and regulatory sources establish the limits of the evidence. Accessed October 8, 2026.
- CoreAge Rx: current advertised treatments and pricesProvider starting prices; final plan and billing terms require confirmation
- FDA: concerns with unapproved GLP-1 drugsCompounded-product risks, salt forms, dosing errors and online red flags
- NIDDK: prescription medicines for overweight and obesityEligibility, long-term care, treatment context and insurance questions